POLYPHARMACY PARADOX: UNRAVELING ENTERIC ULCER CONUNDRUM
AbstractBackground/Aims: Polypharmacy, the concurrent use of multiple medications by a single patient, is common in modern healthcare to manage multiple comorbidities. While it helps address complex health conditions, it also brings significant challenges, such as increased risks of drug interactions and adverse effects, including the development of enteric ulcerlesions in the gastrointestinal tract. Methods: This research paper examines the complex relationship between polypharmacy and enteric ulcer formation through a comprehensive literature review. It investigates the mechanisms behind enteric ulcer development and the impact of polypharmacy on gastrointestinal physiology. Results: By analyzing the interactions and consequences of multiple medications on gastrointestinal health, this paper provides valuable insights for clinicians. These insights are aimed at optimizing medication regimens to reduce the risk of enteric ulcers and enhance patient outcomes. This paper aims to clarify the paradox of polypharmacy in relation to enteric ulcer formation. It highlights the complex interactions between multiple medications and gastrointestinal health, offering guidance for healthcare professionals. This guidance is essential for balancing the therapeutic benefits of polypharmacy against its potential risks, particularly the development of enteric ulcers. Conclusions: Through this detailed review, the paper contributes to a better understanding of effective polypharmacy management, ensuring patients receive the most beneficial and least harmful medication combinations.
Article Information
16
3265-3272
813 KB
73
English
IJPSR
Rishav Brijpuriya and Neelam Balekar *
IPS Academy College of Pharmacy, Rajendra Nagar, A.B. Road Indore, Madhya Pradesh, India.
neelambalekar@ipsacademy.org
05 June 2024
30 June 2024
17 July 2024
10.13040/IJPSR.0975-8232.15(11).3265-72
01 November 2024